$4550
The manufacturing execution system in life sciences market is projected to reach US$ 10,456.54 million by 2033 from US$ 3,139.14 million in 2022; it is expected to grow at a CAGR of 12.0% during 2023–2033.
The manufacturing execution system (MES) is a comprehensive, dynamic solution that helps track, monitor, document, and control the process of goods manufacturing, from raw materials to finished products. These solutions also provide decision-makers with multivariate data, which can be utilized for optimizing plant floor operations and enhancing production efficiency. In addition, implementing an MES in pharmaceutical manufacturing plants helps manufacturers improve scheduling and resource utilization, enhance manufacturing flexibility and process changeover, reduce work in progress (WIP), improve material tracking, shorten production cycles, lower production record errors, and minimize product recalls.
Manufacturing Execution System in Life Sciences Market -
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Manufacturing Execution System in Life Sciences Market: Strategic Insights
Market Size Value in US$ 3,139.14 million in 2022 Market Size Value by US$ 10,456.54 million by 2033 Growth rate CAGR of 12.0% from 2023 to 2033 Forecast Period 2023-2033 Base Year 2022
Naveen
Have a question?
Naveen will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Manufacturing Execution System in Life Sciences Market: Strategic Insights
| Market Size Value in | US$ 3,139.14 million in 2022 |
| Market Size Value by | US$ 10,456.54 million by 2033 |
| Growth rate | CAGR of 12.0% from 2023 to 2033 |
| Forecast Period | 2023-2033 |
| Base Year | 2022 |
Naveen
Have a question?
Naveen will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Rise in Adoption of Pharma 4.0 Drives Manufacturing Execution System in Life Sciences Market Growth
The growing digitization in the pharmaceutical industry is raising the demand for Pharma 4.0 among the factors contributing to the growing manufacturing execution system in Life sciences market size. The model helps increase connectivity and productivity, simplify compliance, and marshal production information to respond to problems as they emerge. The Pharma 4.0 model helps transform the manufacturing process by connecting workers to more human-centric workflows. The International Society for Pharmaceutical Engineering (ISPE) and its members are developing a roadmap to introduce Pharma 4.0. The objective of the Pharma 4.0 model is to enable organizations to leverage the full potential of digitalization to provide faster therapeutic innovations and improve production processes for patients’ benefit.
Key players in the Pharma 4.0 ecosystem are collaborating to accelerate the adoption of the same. For instance, in March 2021, Lonza and NNIT announced a partnership to speed up MES projects. Under this partnership, the companies will combine Lonza’s MODA Platform with NNIT’s Accelerated Implementation Methodology. With this, the companies will get a complete Pharma 4.0 solution and achieve their digitalization vision faster than ever. Therefore, the increasing adoption of Pharma 4.0 boosts the manufacturing execution system in life sciences market growth.
Lucrative Regions for Manufacturing Execution System in Life Sciences Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights – Manufacturing Execution System in Life Sciences Market
Based on region, the market manufacturing execution system market is classified into North America, Europe, Asia Pacific, South America, and the Middle East & Africa. North America dominated the manufacturing execution system in life sciences market share in 2022. The market in this region is further segmented into the US, Canada, and Mexico. North America is one of the developed regions. Pharmaceuticals, biotechnology, and many other industries in the region are known for the adoption of highly advanced technologies and automated operations. Pharmaceutical, medical device manufacturing, and biotechnology companies are implementing MES to improve the productivity and management of their production units. Companies such as Abbot, Baxter International, Genitope Corporation, and Merck & Co. Thus, the growing adoption of digital transformation is expected to boost the manufacturing execution system in life sciences market size in North America in the coming years.
Deployment-Based Insights
The manufacturing execution system in life sciences market, by deployment, is segmented into cloud and on-premise. The on-premise segment held the larger manufacturing execution system in life sciences market share in 2022, but the cloud segment is expected to record a higher CAGR during the forecast period. The cloud segment is growing considerably due to several advantageous characteristics, such as scalability and cost-effectiveness. Cloud Native MES are offered in the form of a software-as-a-service (SaaS) solution that runs over the internet. Such MES solutions allow all involved personnel to access real-time jobs that can be performed at any time. With the increasing adoption of Pharma 4.0, pharmaceutical companies are exhibiting a rapid shift to cloud-based solutions. Major MES providers are also taking steps to promote and support this shift. In February 2023, General Electric announced the incorporation of cloud-based MES software in the "Proficy Smart Factory Portfolio."
The manufacturing execution system in life sciences market is segmented on the basis of offering, deployment, organization size, and application. Based on offering, the manufacturing execution system in life sciences market is bifurcated into software and services. In terms of deployment, the manufacturing execution system in life sciences market is segmented into on-premise and cloud. by organization size, the manufacturing execution system in life sciences market is segmented into SMEs and large enterprises. Based on application, the manufacturing execution system in life sciences market is segmented into pharmaceutical, biotechnology, and medical devices. Based on geography, the manufacturing execution system in life sciences market is primarily segmented into North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South America (SAM).
Korber AG, Siemens AG, General Electric, Emerson Electric, Schneider, Rockwell Automation, Apprentice FS Inc, ATS Global, Atachi Systems, LZ Lifescience Ltd, POMS Corporation, and Schneider Electric are among the key players in the manufacturing execution system in life sciences market.
Manufacturing execution system in life sciences market players mainly focus on partnerships to create customer value.
- In May 2022, Eyelit a provider of manufacturing execution (MES), quality management system (QMS), and factory automation solutions announced the acquisition of MESTEC, a UK-based manufacturing Software as a Service (SaaS) vendor. The partnership of the two customer-centric solution providers will enable Eyelit to provide manufacturing software solutions to a broad set of industries.
- In September 2022, Siemens Digital Industries Software signed a new Original Equipment Manufacturer (OEM) partnership with Cybord.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Offering, Deployment, Organization Size, and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The global manufacturing execution system in life sciences market was estimated to be US$ 3,139.14 million in 2022 and is expected to grow at a CAGR of 12.0%, during the forecast period 2023 - 2033.
Manufacturing execution system in life sciences market is being driven by the need for compliance with regulatory framework and requirement of accurate real-time data in production management process. Additionally, rising application in cell and gene therapy sector are expected to provide growth opportunities for the manufacturing execution system in life sciences market.
Increasing shift from legacy to modern MES are expected to play a crucial role in the future of the manufacturing execution system in life sciences market. It helps enhance pharmaceutical industry production processes without requiring custom coding. Additionally, the fast and flexible responsiveness of the modern MES solution will make it easier to change production lines and accommodate small batches.
The key players, holding majority shares, in manufacturing execution system in life sciences market includes Korber AG, Siemens AG, Emerson Electric, Rockwell Automation, and Dassault Systemes.
Asia Pacific is the fastest growing regional market, followed by Europe.
India, China, and Germany are expected to register high growth rates during the forecast period.
The US held the largest market share in 2022, followed by Germany.
The services segment led the manufacturing execution system in life sciences market with a significant share in 2022 and expected to be fastest growing.
The manufacturing execution system in life sciences market is expected to reach US$ 10,456.54 million by 2033.
The incremental growth, expected to be recorded for the manufacturing execution system in life sciences market during the forecast period, is US$ 7,083.22 million.
The List of Companies - Manufacturing Execution System in Life Sciences Market
- Korber AG
- Siemens AG
- Emerson Electric
- Schneider Electric
- Rockwell Automation
- Apprentice FS Inc
- ATS Global
- Atachi Systems
- LZ Lifescience Ltd
- POMS Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2023
Printing Machinery and Equipment Market
Forecast to 2030 - Global Analysis by Operation (Manual and Automatic), Product Type (Offset Lithography, Flexography, Screen, Digital, and Others), Substrate Type (Plastic, Paper & Paperboard, Metal, and Others), and End Use (Commercial, Publication, and Others)
Mar 2023
Smart Life Sciences Manufacturing Market
Forecast to 2033 - COVID-19 Impact and Global Analysis by Component (Solutions and Services), Technology [AR/VR Systems, Internet of Things (IoT), Artificial Intelligence (AI), Cybersecurity, Big Data, and Others], and Application (Pharma, Bio-Pharma, and Medical Device)
Mar 2023
Manufacturing Execution System in Life Sciences Market
Forecast to 2033 - COVID-19 Impact and Global Analysis By Offering (Software and Services), Deployment (On-Premises and Cloud), Organization Size (SMEs and Large Enterprises), and Application (Pharmaceutical, Biotechnology, and Medical Devices)
Mar 2023
Event Apps Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Enterprise Event Apps, Hybrid Apps, Corporates Meeting Apps, Conference Apps, Trade Show Apps, Festival Apps, and Sports Event Apps), Operating System (iOS, Android, and Web-based), and End User (Event Organizer and Planners, Corporates, Government, Education, and Others)
Mar 2023
A2P SMS and CPaaS Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Component (Solution and Services), Channel [Message (Chat Apps and SMS), Voice, Email, Webpush, and Others], Enterprise Size (SMEs and Large Enterprises), and Industry (IT & Telecom, BFSI, Retail & E-commerce, Healthcare, and Others)
Mar 2023
Event Management Platform Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Component [Hardware (Physical and Hybrid Check-in), Software, and Services (Professional Services, Managed Services)], Deployment (On Premise and Cloud-based), Application (Event Planning, Event Registration and Ticketing, Event
Mar 2023
Big Data Analytics Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Component (Software and Services), Analytics Tool (Dashboard and Data Visualization, Data Mining and Warehousing, Self-Service Tool, Reporting, and Others), Application (Customer Analytics, Supply Chain Analytics,